Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross
June 20, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY NJ, June 20, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that its ThyGeNEXT™ and ThyraMIR® tests for thyroid cancer are now covered by...